Ningxia Zhongke Biotechnology Co., Ltd. Class ASSE: 600165

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Announcement on SSE's Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report

Jul 1, 2026 · Issued by Ningxia Zhongke Biotechnology Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on SSE's Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Ningxia Zhongke Biotechnology Co., Ltd. Class A

Announcement on Progress in External Investment and Completion of Industrial and Commercial Change Registration and Obtaining of the Business LicenseJun 30
Announcement on Changing Implementation Entity for Outward Investment ProjectsJun 13

All Ningxia Zhongke Biotechnology Co., Ltd. Class A news releases